Cargando…
A Risk-benefit Assessment Approach to Selection of Adjuvant Chemotherapy in Elderly Patients with Early Breast Cancer: A Mini Review
Decision-making regarding the use and selection of adjuvant chemotherapy for breast cancer in elderly patients is challenging due to the presence of age-related comorbidities, frailty, and competing causes of mortality. One area, relatively neglected in most guidelines, is the effect of competing ca...
Autores principales: | Agarwala, Vivek, Choudhary, Neha, Gupta, Sudeep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759076/ https://www.ncbi.nlm.nih.gov/pubmed/29333024 http://dx.doi.org/10.4103/ijmpo.ijmpo_96_17 |
Ejemplares similares
-
Adjuvant chemotherapy for early breast cancer.
por: Henderson, I. C.
Publicado: (1990) -
Adjuvant chemotherapy in locally advanced cervical cancer: the ceiling remains unbroken
por: Gupta, Sudeep
Publicado: (2019) -
Adjuvant Chemotherapy Benefit in Elderly Stage II/III Colon Cancer Patients
por: Chen, Xin, et al.
Publicado: (2022) -
Adjuvant chemotherapy and HER-2-directed therapy for early-stage breast cancer in the elderly
por: Sun, J, et al.
Publicado: (2017) -
Could Adjuvant Chemotherapy after Surgery Benefit Elderly Patients with Advanced Gastric Cancer?
por: Jeong, Jin Woon, et al.
Publicado: (2016)